Pharma · AI · Transformation
Commercial and AI transformation in life sciences
Notes and reflections on commercial excellence, AI and how large organisations change, from two decades working across pharma and consumer goods.
Insights
Recent writing
-
Faster with AI is not a new model!
Reflections from our panel on AI and new trends in commercial models at the GCSFE Summit in Berlin.
-
Only 6% of companies get real value from AI. What sets them apart?
According to McKinsey, the few companies that get real value from AI have one thing in common, and it isn’t better technology.
-
Most people use AI. Few use it in ways that matter.
The bottleneck is no longer adoption. It is what comes after adoption.
About
Engineer by training, commercial leader by choice, learner by habit
Twenty+ years in commercial and transformation roles at Procter & Gamble and Pfizer, in global and regional leadership positions across more than 40 markets. Home has been Istanbul, Warsaw, Cincinnati, New York and, for the last eight years, Berlin.
My path has zig-zagged between P&L and brand roles and digital and transformation roles. Today I focus on commercial excellence and AI in healthcare, and I write here about what I see working and what does not.
Speaking & media
On stage and in conversation
Interview · Turkish Global Society · 2024
“Without learning, there is no me”
A long-form magazine interview on learning, living abroad, digital marketing and AI in pharma.
Video · AVRUPADAN · Yeni Gelenler
In conversation with Oktan Erdikmen
A video interview in Turkish about building a career in Germany and leading across cultures.
Archive · 2009–2022
Earlier articles and interviews
Contact
Let’s connect
I am always happy to exchange ideas on commercial excellence, AI and healthcare. The best way to reach me is on LinkedIn.
